Core Laboratories Increases Sales but Misses Revenue Estimate

Before you go, we thought you'd like these...
Before you go close icon

Core Laboratories (NYS: CLB) reported earnings on April 18. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended March 31 (Q1), Core Laboratories missed slightly on revenue and met expectations on earnings per share.

Compared to the prior-year quarter, revenue increased and GAAP earnings per share improved significantly.


Margins expanded across the board.

Revenue details
Core Laboratories chalked up revenue of $234.2 million. The eight analysts polled by S&P Capital IQ wanted to see revenue of $238.5 million on the same basis. GAAP reported sales were 13% higher than the prior-year quarter's $206.7 million.

anImage

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Non-GAAP EPS came in at $1.06. The nine earnings estimates compiled by S&P Capital IQ anticipated $1.07 per share on the same basis. GAAP EPS of $1.13 for Q1 were 20% higher than the prior-year quarter's $0.94 per share.

anImage

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 36.3%, 240 basis points better than the prior-year quarter. Operating margin was 31.6%, 490 basis points better than the prior-year quarter. Net margin was 23.0%, 60 basis points better than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $254.4 million. On the bottom line, the average EPS estimate is $1.16.

Next year's average estimate for revenue is $1.04 billion. The average EPS estimate is $4.76.

Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 547 members rating the stock outperform and 14 members rating it underperform. Among 140 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 137 give Core Laboratories a green thumbs-up, and three give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Core Laboratories is outperform, with an average price target of $121.00.

Are you missing a big story in the energy space? Read about "The One Stock You Need To Own for the Coming 'No Choice' Energy Revolution." Click here for instant access to this free report.

At the time this article was published Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners